Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I can personally attest to both the onset and duration. Onset was literally within hours, and in full effect by day 2. Going on 5 months now, and still going strong.
Well that is a very dull earnings report. No surprises good or bad period. I hope the CEO can add some color to the report.
Good luck today, Marjac. Whatever the result you have given it your best. And that's all I, as an onlooker, could have hoped for.
Agree 1000%.
Volume coming in.
Sarissa may be responsible by selling a chunk of the shares they own to bring down the price to force out a larger holder (retail included). Easy when there is lower volume. Keeping my finger on the buy button.
Thanks for the information. I will bring this, and other recommendations, up with the doc. And thanks to others for the well wishes. I was on Prednisone for 45 days with little relief, now taking Cymbalta, Gabapentin, Celebrex, and baclofen. Something has to work.
I haven't seen anyone post the I-Recover Protocol. Here's a link:
https://covid19criticalcare.com/covid-19-protocols/i-recover-protocol/
I have long covid. Waiting in a doctor office to see a specialist as I write this. Previous doctor printed off a protocol for long covid and it lists Vascepa by name as a treatment option. I've been suffering from non stop headaches since having Covid in August. Thought I'd ask the specialist for a script.
Be prepared for a wild ride in the next 30-60 days and, IMO, buy every share you can afford. Keep your foot on the petal and your paper losses will quickly become some of the largest investment gains of your trading career. Hindsight is 20/20, and we all wish we sold at $26, but we now have the opportunity to eclipse our previous paper gains by averaging down and adding here. I added again early this morning to put my share count well over 200K. I have no intention to trade a single share from here. I will wait for my account to be credited with cash and stock of the suitor. I could tell you my valuation method and logic behind the buyout window I have been referring to, but this is my research, and I am not here to explain myself. But I stand firm on a $16 price tag.
Because the entire company has been filled with incompetent placeholders with the belief that a buyout was imminent post Reduce-It. This company's management is a joke, and will all be back on the breadline as soon as the buyout is complete.
Is the mass murdering Du going to fund this trial?
Perfect weather for smart money accumulation. If we dip below 4 it will be very, very temporary.
Definitely do not hold your breath for over $24. You will die in short order. My analysis puts the buyout price shy of $16. Could Amarin be worth over $16 GAL?. Absolutely. But the company is prone to failure on all fronts, and investors have grown weary and are ready to throw in the towel.
I'm not hear to boost anyone's moral or to try and pump this stock. Just giving my two cents that I believe the stars have now aligned for a buyout, and the rumors will start floating early December, with an offer on the table shortly thereafter. And, IMO it's going to come down to Gilead and Pfizer. I sold off a quarter of my holdings several weeks ago expecting another shakedown with the low volume we've been seeing, and have gone back all in on Friday.
I have nothing more to give than my opinion, and I've not once said in a previous post a buyout is imminent. A few months back I did opine the buyout window has opened. This window will be shut very soon. The smart money has bought the January calls.
Kudos to those who are buying right now. You no doubt will be having extra Christmas presents under the tree this year. It may not be in your new beach house, but at least the show is coming to an end and we can all move forward with our lives. Tick tock. Tick tock.
You and your threats. You should get tossed from this board.
Am I missing something? Where does Merck state 0 deaths? I only see 0 deaths after 30 days of treatment.
They've obviously taken a short position yesterday. Would be nice to see the apes jump in today to flush out these losers.
I will add $25,000 to the pot, regardless of the stock price. Just restore the patents!
Not to mention the RRR is a function of time and events. Imagine if the study lasted another 2 or 3 years. 35% may very well be 45% or, dare we say, the odds of a second, third, or fourth heart attack could be cut in half.
These are the e-Posters we have been looking for.
A prelude to the Prepare-It results?
Thanks!
I thought the e-Posters were supposed to all be made available today. Is this not the case?
For the legal beagles out there--Does Hall's recent decision, combined with the GSK vs Teva decision, provide any room for Amarin to request an injunction?
I think you need to read up on purchasing power parity.
Who's to say Amarin even has the data? Pablo would be under no obligation to release this information to Amarin any sooner than the rest of us. And any information released could be strictly confidential.
I stopped reading sts66's post after seeing "21 patients".
Business 101, analyze your strengths, weaknesses, opportunities, and threats. Turn your weaknesses into strengths, and your threats into opportunities. Amarin management has relied solely on its strengths (the Reduce-It data), and ignored all other facets of the SWOT analysis. A recipe for disaster. I won't post again of Management's embarrassing performance. We get enough repetition here from Couldbebetter. I look forward to a new strategy from the incoming CEO.
How do you stop Vascepa from impacting BP pipelines worth hundreds of billions, if not trillions of dollars, with the least amount of effort and capital outlay?
Step 1: Prevent other BP's from acquiring the company.
Step 2: Prevent Amarin from becoming a BP itself.
Step 3: Attack the reputation of the drug.
Step 1 was accomplished by being the highest bidder, but conditional on events of which the bidder was actually in full control of.
Step 2 was, and continues to be accomplished through both the FDA and our corrupt court system.
Step 3 is underway, and I fully expect this to ramp up to levels that we have yet to see the likes of. Steps 2 and 3 can be repeated in ROW.
The BP front runner in the potential BO had been stringing Amarin along likely for several years, all the while sabataging Amarin at every turn. Whom JT considered his biggest ally was actually his worst enemy in disguise. JT and board bought this hook line & sinker. To avoid embarrassment, JT and board came to an amicable agreement for his departure, and we will never know the actual events that have transpired. This so called buyer had one objective. To kill this drug. The end. [APPLAUSE]
Amarin management is responsible for the reputation of its only product. I had written Thero on numerous occasions for the past 2.5 years that Amarin cannot continue to turn a blind eye to critics such as Nissen, Herper, and Feuerstein, and the short and distort campaigns led by MRC and Sharma. Amarin sat idly by while its reputation was tarnished over and over. There level of incompetence is second to none.
Are you being serious or facetious?
As we near the halfway point from the date of the pole, it looks like BioFalcon and myself are neck-and-neck. Truly astounding how management can take a product that should sell itself and...well we all know the rest of the story.
I was just having fun with your missing "r". I hear your point loud and clear.
County by county? Great. Sounds like a typical Amarin strategy.
Ha! Of course not. Thought I'd try the same strategy I use on my kids.
How about you spend less time here whining like a little baby and more time trying to educate the media about the potential of this drug?